Investigating a potential treatment target for osteoarthritis
CaMKK2 Signaling in Osteoarthritis
This study is looking at a protein called CaMKK2 to see if blocking it can help protect your joints from damage and inflammation caused by osteoarthritis, with the hope of finding new ways to treat the condition instead of just easing the pain.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Indiana University Indianapolis NIH-funded |
| Lab location | 1 site (Indianapolis, United States) |
| Project ID | NIH-10763887 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of CaMKK2, a protein involved in cellular signaling, in the development and progression of osteoarthritis (OA). The study aims to explore how inhibiting CaMKK2 can protect against cartilage degradation and inflammation in OA, which is a painful and debilitating joint condition. Using a murine model, researchers will examine the effects of genetic and pharmacological interventions on joint health. The ultimate goal is to identify new therapeutic strategies that could modify the disease rather than just manage symptoms.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults suffering from osteoarthritis, particularly those experiencing significant joint pain and mobility issues.
Not a fit: Patients with osteoarthritis who are not responsive to treatments or have advanced joint damage may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that slow down or even reverse the progression of osteoarthritis, improving quality of life for patients.
How similar studies have performed: Previous research has shown promise in targeting similar molecular pathways for treating osteoarthritis, suggesting that this approach may yield beneficial results.
Where this research is happening
Indianapolis, United States
- Indiana University Indianapolis — Indianapolis, United States (Active)
Researchers
- Principal investigator: Sankar, Uma — Indiana University Indianapolis
- Study coordinator: Sankar, Uma
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.